Goss Wealth Management »

Fibrobiologics shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $114k 23k 4.99
2024-03-31 $194k 18k 10.81

More positions owned by Goss Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Goss Wealth Management

Top funds holding Fibrobiologics

BlackRock
State Street Corporation
Geode Capital Management
Cascade Financial Partners
Vanguard Group
Carnick & Kubik
Requisite Capital Management
American Institute for Advanced Investment Management
Bank of America Corporation
Bank of New York Mellon
Charles Schwab Investment Management
RMR Wealth Builders
Concurrent Investment Advisors
Nuveen Asset Management
ERn Financial

View all funds holding Fibrobiologics